JP2003512426A - 双極性気分障害における躁病の治療のための１−アミノインダンの使用。 - Google Patents

双極性気分障害における躁病の治療のための１−アミノインダンの使用。

Info

Publication number
JP2003512426A
JP2003512426A JP2001532759A JP2001532759A JP2003512426A JP 2003512426 A JP2003512426 A JP 2003512426A JP 2001532759 A JP2001532759 A JP 2001532759A JP 2001532759 A JP2001532759 A JP 2001532759A JP 2003512426 A JP2003512426 A JP 2003512426A
Authority
JP
Japan
Prior art keywords
administration
salt
alkyl
hydrogen
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001532759A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003512426A5 (enExample
Inventor
バラク、ガブリエラ
レビー、ルース
Original Assignee
テバ ファーマシューティカル インダストリーズ リミティド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by テバ ファーマシューティカル インダストリーズ リミティド filed Critical テバ ファーマシューティカル インダストリーズ リミティド
Publication of JP2003512426A publication Critical patent/JP2003512426A/ja
Publication of JP2003512426A5 publication Critical patent/JP2003512426A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2001532759A 1999-10-27 2000-10-27 双極性気分障害における躁病の治療のための１−アミノインダンの使用。 Pending JP2003512426A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16181799P 1999-10-27 1999-10-27
US60/161,817 1999-10-27
PCT/US2000/029618 WO2001030339A1 (en) 1999-10-27 2000-10-27 Use of 1-aminoindan derivatives for treatment of mania in bipolar mood disorder

Publications (2)

Publication Number Publication Date
JP2003512426A true JP2003512426A (ja) 2003-04-02
JP2003512426A5 JP2003512426A5 (enExample) 2007-12-27

Family

ID=22582876

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001532759A Pending JP2003512426A (ja) 1999-10-27 2000-10-27 双極性気分障害における躁病の治療のための１−アミノインダンの使用。

Country Status (9)

Country Link
US (1) US6492426B1 (enExample)
EP (1) EP1242066B1 (enExample)
JP (1) JP2003512426A (enExample)
AT (1) ATE331508T1 (enExample)
AU (1) AU775885B2 (enExample)
CA (1) CA2387394C (enExample)
DE (1) DE60029131T2 (enExample)
IL (2) IL149308A0 (enExample)
WO (1) WO2001030339A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014534196A (ja) * 2011-10-10 2014-12-18 テバ ファーマシューティカル インダストリーズ リミティド Ｒ（＋）−ｎ−ホルミル−プロパルギル−アミノインダン

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9181026B2 (en) 2013-10-03 2015-11-10 Custom Chemical Solutions, LLC Containment berm with internal “L” braces
WO2024196698A2 (en) * 2023-03-17 2024-09-26 Curadh Mtr Compounds and constructs useful for targeting fibroblast activation protein

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3637740A (en) * 1969-04-21 1972-01-25 Pfizer Aminobenzocycloalkane compounds
JPS53130644A (en) * 1977-03-28 1978-11-14 Lilly Co Eli 11aminoindane compound
JPS5824433A (ja) * 1981-08-06 1983-02-14 Takehiro Mokuzai Kogyo Kk 繊維材成型品の表面化粧方法
JPH03294248A (ja) * 1990-01-03 1991-12-25 Teva Pharmaceut Ind Ltd Ｎ−プロパルギル−１−アミノインダン化合物のｒ（＋）−鏡像体、それらの製造法およびそれらを含有する薬剤組成物
JPH09510188A (ja) * 1994-01-10 1997-10-14 テバ・ファーマシューティカル・インダストリーズ・リミテッド １−アミノインダン及びこれらの組成物

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB852735A (en) 1956-04-13 1960-11-02 Schering Ag Manufacture of 1-aminoindanes
BE786748A (fr) * 1971-07-26 1973-01-26 Basf Ag 1-aminomethyl-indanes-n-substitues
KR910003337B1 (ko) 1983-03-04 1991-05-27 오오쓰까세이야꾸 가부시끼가이샤 인단 유도체 및 그 염의 제조방법
US5242919A (en) 1984-08-31 1993-09-07 Otsuka Pharmaceutical Co., Ltd. 2,3-dihydro-1H-indene derivatives
EP0173331B1 (en) 1984-08-31 1991-08-14 Otsuka Pharmaceutical Co., Ltd. 2,3-dihydro-1h-indene derivatives, a process for preparing them and pharmaceutical compositions containing same
JPS6169747A (ja) 1984-08-31 1986-04-10 Otsuka Pharmaceut Co Ltd ２，３―ジヒドロ―１ｈ―インデン誘導体及びその製造法
US4882339A (en) 1987-07-10 1989-11-21 Ciba-Geigy Corporation 4-Amino-substituted 1,2-dihydroxynaphthalene derivatives useful in inhibiting 5-lipoxygenase activity in mammals
US5744500A (en) 1990-01-03 1998-04-28 Teva Pharmaceutical Industries, Ltd. Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof
IL99759A (en) 1991-10-16 1997-06-10 Teva Pharma Mono-fluorinated derivatives of n-propargyl-1-aminoindan, their preparation and pharmaceutical compositions containing them
US5344836A (en) 1991-11-11 1994-09-06 Ono Pharmaceutical Co., Ltd. Fused benzeneoxyacetic acid derivatives
CH683996A5 (fr) 1992-03-05 1994-06-30 Symphar Sa Dérivés aminophosphonates substitués, leur procédé de préparation et compositions pharmaceutiques les contenant.
CN1052224C (zh) 1993-04-07 2000-05-10 大塚制药株式会社 哌啶衍生物、含有它的外周血管舒张剂及其应用
IL111240A (en) 1993-10-18 2001-10-31 Teva Pharma Salts of r(+) - enantiomers of n- propargyl-1-aminoindan and pharmaceutical compositions comprising them
US5914349A (en) 1994-01-10 1999-06-22 Teva Pharmaceutical Industries, Ltd. Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives
CH690264A5 (fr) 1995-06-30 2000-06-30 Symphar Sa Dérivés aminophosphonates substitués, leur procédé de préparation et leur utilisation pour la préparation de compositions pharmaceutiques.
US5646188A (en) 1995-07-05 1997-07-08 Teva Pharmaceutical Industries, Ltd. Polyamine derivatives of 1-aminoindan
IL115357A (en) 1995-09-20 2000-01-31 Teva Pharma Stable compositions containing N-propargyl-1-aminoindan and polyhydric alcohols
US5887218A (en) 1996-06-10 1999-03-23 Ricoh Co., Ltd. Color image forming apparatus having toner and transfer sheet bearing members and image forming method thereof
CA2275425C (en) 1996-12-18 2009-08-04 Michael Chorev Aminoindan derivatives
US6251938B1 (en) 1996-12-18 2001-06-26 Teva Pharmaceutical Industries, Ltd., Phenylethylamine derivatives
WO1998055447A1 (en) 1997-06-05 1998-12-10 Venantius Limited 3-aminoindane derivatives, process for their preparation and pharmaceutical compositions containing them
US5887221A (en) 1997-10-20 1999-03-23 Xerox Corporation Signature sensing for optimum toner control with donor roll
US6227886B1 (en) 1999-04-16 2001-05-08 Avaya Technology Corp. Snag-resistant patchcord plug latch and cover

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3637740A (en) * 1969-04-21 1972-01-25 Pfizer Aminobenzocycloalkane compounds
JPS53130644A (en) * 1977-03-28 1978-11-14 Lilly Co Eli 11aminoindane compound
JPS5824433A (ja) * 1981-08-06 1983-02-14 Takehiro Mokuzai Kogyo Kk 繊維材成型品の表面化粧方法
JPH03294248A (ja) * 1990-01-03 1991-12-25 Teva Pharmaceut Ind Ltd Ｎ−プロパルギル−１−アミノインダン化合物のｒ（＋）−鏡像体、それらの製造法およびそれらを含有する薬剤組成物
JPH09510188A (ja) * 1994-01-10 1997-10-14 テバ・ファーマシューティカル・インダストリーズ・リミテッド １−アミノインダン及びこれらの組成物

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014534196A (ja) * 2011-10-10 2014-12-18 テバ ファーマシューティカル インダストリーズ リミティド Ｒ（＋）−ｎ−ホルミル−プロパルギル−アミノインダン

Also Published As

Publication number Publication date
ATE331508T1 (de) 2006-07-15
CA2387394C (en) 2009-08-18
DE60029131T2 (de) 2007-01-18
US6492426B1 (en) 2002-12-10
EP1242066A1 (en) 2002-09-25
AU775885B2 (en) 2004-08-19
CA2387394A1 (en) 2001-05-03
IL149308A0 (en) 2002-11-10
DE60029131D1 (de) 2006-08-10
WO2001030339A1 (en) 2001-05-03
AU1440201A (en) 2001-05-08
EP1242066A4 (en) 2004-09-01
IL149308A (en) 2007-07-24
EP1242066B1 (en) 2006-06-28

Similar Documents

Publication Publication Date Title
US8883808B2 (en) Combination of 5-HT7 receptor antagonist and serotonin reuptake inhibitor therapy
US20100256145A1 (en) Use of kcnq potassium channel openers for reducing symptoms of or treating disorders or conditions wherein the dopaminergic system is disrupted
EP2627328B1 (en) Combinations of serotonin receptor agonists for treatment of movement disorders
JP2002542287A (ja) 医 薬
EP2468732B1 (en) 1H-Quinazoline-2,4-diones
JP2001516718A (ja) ５−ＨＴ再取り込み阻害剤およびｈ５−ＨＴ１Ｂアンタゴニストまたは部分的アゴニストの組み合わせ
US20140243350A1 (en) Use of serotonin receptor agonists for treatment of movement disorders
JP2003012518A (ja) 痙攣または発作を処置または予防するための組成物および方法
AU752192B2 (en) The use of valproic acid analog for the treatment and prevention of migraine and affective illness
US20140221385A1 (en) Combinations of serotonin receptor agonists for treatment of movement disorders
KR20110021946A (ko) 니코틴 수용체 부분 효능제와 아세틸콜린에스테라제 억제제의 조합물, 이를 함유하는 제약 조성물, 및 인지 장애를 치료하는 데에 있어서의 그의 용도
US20050119285A1 (en) Treatment of neurological disorders related to rapid eye movement (REM) sleep disturbances with NPY Y5 receptor antagonists
KR102301073B1 (ko) 시노카브 또는 이의 약학적으로 허용가능한 염을 포함하는 약학적 조성물 및 이를 이용하여 운동이상증 및 관련 장애를 치료하는 방법
Tortella et al. EEG seizure activity and behavioral neurotoxicity produced by (+)-MK801, but not the glycine site antagonist L-687,414, in the rat
EP1832286A1 (en) Preventive or therapeutic agent for sleep disorder
CA2387394C (en) Use of 1-aminoindan derivatives for treatment of mania in bipolar mood disorder
CN114728961A (zh) Kv7通道激活剂的使用方法
EP4052702A1 (en) Cxcl8 inhibitor and pharmaceutical composition thereof for use in the treatment of seizures
JP2001516717A (ja) 選択的５−ＨＴ１Ａアンタゴニストおよび選択的ｈ５−ＨＴ１Ｂアンタゴニストまたは部分的アゴニストの組み合わせ
JP2003532672A (ja) フェルバマート誘導化合物
Dwivedi et al. Overview Central & Peripheral Nervous Systems: Anti-epileptic agents: recent developments
HK1168591B (en) 1h-quinazoline-2,4-diones
HK1168591A (en) 1h-quinazoline-2,4-diones
HK1111597A (en) Preventive or therapeutic agent for sleep disorder
HK1129593B (en) Use of kcnq-opener for the preparation of a pharmaceutical composition for treating schizophrenia

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20071026

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20071026

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110118

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20110628